Towards development of a dermal rudiment for enhanced wound healing response

Yolanda Garcia, Brendan Wilkins, Russell Collighan, Martin Griffin, Abhay S. Pandit

Research output: Contribution to journalArticle

Abstract

Enhancement of collagen's physical characteristics has been traditionally approached using various physico-chemical methods frequently compromising cell viability. Microbial transglutaminase (mTGase), a transamidating enzyme obtained from Streptomyces mobaraensis, was used in the cross-linking of collagen-based scaffolds. The introduction of these covalent bonds has previously indicated increased proteolytic and mechanical stability and the promotion of cell colonisation. The hypothesis behind this research is that an enzymatically stabilised collagen scaffold will provide a dermal precursor with enhanced wound healing properties. Freeze-dried scaffolds, with and without the loading of a site-directed mammalian transglutaminase inhibitor to modulate matrix deposition, were applied to full thickness wounds surgically performed on rats’ dorsum and explanted at three different time points (3, 7 and 21 days). Wound healing parameters such as wound closure, epithelialisation, angiogenesis, inflammatory and fibroblastic cellular infiltration and scarring were analysed and quantified using stereological methods. The introduction of this enzymatic cross-linking agent stimulated neovascularisation and epithelialisation resisting wound contraction. Hence, these characteristics make this scaffold a potential candidate to be considered as a dermal precursor.
LanguageEnglish
Pages857-868
Number of pages12
JournalBiomaterials
Volume29
Issue number7
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Collagen
Scaffolds
Wound Healing
Re-Epithelialization
Transglutaminases
Scaffolds (biology)
Skin
Covalent bonds
Mechanical stability
Streptomyces
Infiltration
Cicatrix
Rats
Cell Survival
Enzymes
Cells
Wounds and Injuries
Research

Keywords

  • cross-linking collagen
  • microbial transglutaminase
  • wound healing
  • angiogenesis
  • stereology

Cite this

Garcia, Yolanda ; Wilkins, Brendan ; Collighan, Russell ; Griffin, Martin ; Pandit, Abhay S. / Towards development of a dermal rudiment for enhanced wound healing response. In: Biomaterials. 2008 ; Vol. 29, No. 7. pp. 857-868.
@article{7d466466e657466ca5ad7339229d6864,
title = "Towards development of a dermal rudiment for enhanced wound healing response",
abstract = "Enhancement of collagen's physical characteristics has been traditionally approached using various physico-chemical methods frequently compromising cell viability. Microbial transglutaminase (mTGase), a transamidating enzyme obtained from Streptomyces mobaraensis, was used in the cross-linking of collagen-based scaffolds. The introduction of these covalent bonds has previously indicated increased proteolytic and mechanical stability and the promotion of cell colonisation. The hypothesis behind this research is that an enzymatically stabilised collagen scaffold will provide a dermal precursor with enhanced wound healing properties. Freeze-dried scaffolds, with and without the loading of a site-directed mammalian transglutaminase inhibitor to modulate matrix deposition, were applied to full thickness wounds surgically performed on rats’ dorsum and explanted at three different time points (3, 7 and 21 days). Wound healing parameters such as wound closure, epithelialisation, angiogenesis, inflammatory and fibroblastic cellular infiltration and scarring were analysed and quantified using stereological methods. The introduction of this enzymatic cross-linking agent stimulated neovascularisation and epithelialisation resisting wound contraction. Hence, these characteristics make this scaffold a potential candidate to be considered as a dermal precursor.",
keywords = "cross-linking collagen, microbial transglutaminase, wound healing, angiogenesis, stereology",
author = "Yolanda Garcia and Brendan Wilkins and Russell Collighan and Martin Griffin and Pandit, {Abhay S.}",
year = "2008",
month = "3",
doi = "10.1016/j.biomaterials.2007.10.053",
language = "English",
volume = "29",
pages = "857--868",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier",
number = "7",

}

Towards development of a dermal rudiment for enhanced wound healing response. / Garcia, Yolanda; Wilkins, Brendan; Collighan, Russell; Griffin, Martin; Pandit, Abhay S.

In: Biomaterials, Vol. 29, No. 7, 03.2008, p. 857-868.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Towards development of a dermal rudiment for enhanced wound healing response

AU - Garcia, Yolanda

AU - Wilkins, Brendan

AU - Collighan, Russell

AU - Griffin, Martin

AU - Pandit, Abhay S.

PY - 2008/3

Y1 - 2008/3

N2 - Enhancement of collagen's physical characteristics has been traditionally approached using various physico-chemical methods frequently compromising cell viability. Microbial transglutaminase (mTGase), a transamidating enzyme obtained from Streptomyces mobaraensis, was used in the cross-linking of collagen-based scaffolds. The introduction of these covalent bonds has previously indicated increased proteolytic and mechanical stability and the promotion of cell colonisation. The hypothesis behind this research is that an enzymatically stabilised collagen scaffold will provide a dermal precursor with enhanced wound healing properties. Freeze-dried scaffolds, with and without the loading of a site-directed mammalian transglutaminase inhibitor to modulate matrix deposition, were applied to full thickness wounds surgically performed on rats’ dorsum and explanted at three different time points (3, 7 and 21 days). Wound healing parameters such as wound closure, epithelialisation, angiogenesis, inflammatory and fibroblastic cellular infiltration and scarring were analysed and quantified using stereological methods. The introduction of this enzymatic cross-linking agent stimulated neovascularisation and epithelialisation resisting wound contraction. Hence, these characteristics make this scaffold a potential candidate to be considered as a dermal precursor.

AB - Enhancement of collagen's physical characteristics has been traditionally approached using various physico-chemical methods frequently compromising cell viability. Microbial transglutaminase (mTGase), a transamidating enzyme obtained from Streptomyces mobaraensis, was used in the cross-linking of collagen-based scaffolds. The introduction of these covalent bonds has previously indicated increased proteolytic and mechanical stability and the promotion of cell colonisation. The hypothesis behind this research is that an enzymatically stabilised collagen scaffold will provide a dermal precursor with enhanced wound healing properties. Freeze-dried scaffolds, with and without the loading of a site-directed mammalian transglutaminase inhibitor to modulate matrix deposition, were applied to full thickness wounds surgically performed on rats’ dorsum and explanted at three different time points (3, 7 and 21 days). Wound healing parameters such as wound closure, epithelialisation, angiogenesis, inflammatory and fibroblastic cellular infiltration and scarring were analysed and quantified using stereological methods. The introduction of this enzymatic cross-linking agent stimulated neovascularisation and epithelialisation resisting wound contraction. Hence, these characteristics make this scaffold a potential candidate to be considered as a dermal precursor.

KW - cross-linking collagen

KW - microbial transglutaminase

KW - wound healing

KW - angiogenesis

KW - stereology

UR - http://www.scopus.com/inward/record.url?scp=37249073805&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2007.10.053

DO - 10.1016/j.biomaterials.2007.10.053

M3 - Article

VL - 29

SP - 857

EP - 868

JO - Biomaterials

T2 - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 7

ER -